AVIRULENT MODIFIED SALMONELLA GALLINARUM STRAINS AND PHARMACEUTICAL COMPOSITION USING THE SAME

摘要

The present invention relates to avirulent modified Salmonella Gallinarum strains produced by inactivating virulence gene clusters of Salmonella Gallinarum (SG), a main pathogen of avian salmonellosis, and various uses thereof notably in the production of Salmonella-specific lytic bacteriophages, pharmaceutical compositions and feed additives.